DK139533C - Fremgangsmaade til fremstilling af inhibitorer for fordoejelsesvejens alfa-glucosidaser - Google Patents

Fremgangsmaade til fremstilling af inhibitorer for fordoejelsesvejens alfa-glucosidaser

Info

Publication number
DK139533C
DK139533C DK635371A DK635371A DK139533C DK 139533 C DK139533 C DK 139533C DK 635371 A DK635371 A DK 635371A DK 635371 A DK635371 A DK 635371A DK 139533 C DK139533 C DK 139533C
Authority
DK
Denmark
Prior art keywords
glucosidases
alfa
inhibitors
procedure
preparation
Prior art date
Application number
DK635371A
Other languages
Danish (da)
English (en)
Other versions
DK139533B (da
Inventor
W Frommer
W Puls
D Schaefer
D Schmidt
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of DK139533B publication Critical patent/DK139533B/da
Application granted granted Critical
Publication of DK139533C publication Critical patent/DK139533C/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/04Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/886Streptomyces
    • Y10S435/896Streptomyces fradiae
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/907Streptosporangium

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Saccharide Compounds (AREA)
DK635371A 1970-12-28 1971-12-27 Fremgangsmaade til fremstilling af inhibitorer for fordoejelsesvejens alfa-glucosidaser DK139533C (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2064092A DE2064092C2 (de) 1970-12-28 1970-12-28 Inhibitoren für Glykosidhydrolasen aus Actinomyceten

Publications (2)

Publication Number Publication Date
DK139533B DK139533B (da) 1979-03-05
DK139533C true DK139533C (da) 1979-08-20

Family

ID=5792372

Family Applications (1)

Application Number Title Priority Date Filing Date
DK635371A DK139533C (da) 1970-12-28 1971-12-27 Fremgangsmaade til fremstilling af inhibitorer for fordoejelsesvejens alfa-glucosidaser

Country Status (28)

Country Link
US (1) US3876766A (pl)
JP (3) JPS5734996B1 (pl)
KR (1) KR780000248B1 (pl)
AR (1) AR193370A1 (pl)
AT (1) AT330122B (pl)
AU (1) AU461521B2 (pl)
BE (1) BE777387A (pl)
BG (3) BG25654A3 (pl)
CA (1) CA979833A (pl)
CH (1) CH594051A5 (pl)
CS (1) CS167961B2 (pl)
DD (1) DD99395A5 (pl)
DE (1) DE2064092C2 (pl)
DK (1) DK139533C (pl)
ES (1) ES398358A1 (pl)
FI (1) FI49774C (pl)
FR (1) FR2120073B1 (pl)
GB (1) GB1374751A (pl)
IE (1) IE35920B1 (pl)
IL (1) IL38441A (pl)
LU (1) LU64319A1 (pl)
NL (1) NL175199C (pl)
NO (1) NO135873C (pl)
PL (1) PL82900B1 (pl)
RO (3) RO63065A (pl)
SE (1) SE398357B (pl)
SU (1) SU454750A3 (pl)
ZA (1) ZA718677B (pl)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2209834C3 (de) * 1972-03-01 1978-04-20 Bayer Ag, 5090 Leverkusen Herstellung von Saccharase-Inhibitoren
DE2209833C3 (de) * 1972-03-01 1978-06-01 Bayer Ag, 5090 Leverkusen Herstellung eines Amylaseinhibitors
DE2209832C3 (de) * 1972-03-01 1979-03-29 Bayer Ag, 5090 Leverkusen Herstellung von Saccharaseinhibitoren
US4062950A (en) * 1973-09-22 1977-12-13 Bayer Aktiengesellschaft Amino sugar derivatives
US4010258A (en) * 1974-03-15 1977-03-01 Ajinomoto Co., Inc. Microbial amylase inhibitor and preparation thereof with the use of streptomyces diasticus var. amylostaticus
US4065557A (en) * 1974-03-21 1977-12-27 Bayer Aktiengesellschaft Amino sugars and their use in improving the meat:fat ratio in animals
US4065562A (en) * 1975-12-29 1977-12-27 Nippon Shinyaku Co., Ltd. Method and composition for reducing blood glucose levels
FR2338707A1 (fr) * 1976-01-22 1977-08-19 Rhone Poulenc Ind Nouvel inhibiteur de glyco-hydrolases et sa preparation par culture d'un streptomyces
DE2658563A1 (de) * 1976-12-23 1978-06-29 Bayer Ag Inhibitoren fuer glykosid-hydrolasen aus bacillen
DE2701890C2 (de) * 1977-01-19 1983-08-04 Hoechst Ag, 6230 Frankfurt Peptielischer Glycosidhydrolase-Inhibitor aus einem Streptomyceten und seine Verwendung
DE2719912C3 (de) * 1977-05-04 1979-12-06 Bayer Ag, 5090 Leverkusen Verfahren zur Isolierung von 0- |4,6-Dideoxy-4- [JJl S-O,4,6/5)-4,5,6-trihydroxy-3-hydroxymethyl-2cyclohexen-1-yl] -amino] - a -D-glucopyranosyl} -(I Pfeil nach rechts 4)-0- a D-glucopyranosyl-(l Pfeil nach rechts 4)-D-glucopyranose aus Kulturbrühen
GB2016497A (en) * 1978-02-10 1979-09-26 Taisho Pharmaceutical Co Ltd Microbiological production of amylase inhibitor
CA1121290A (en) * 1978-02-14 1982-04-06 Yasuji Suhara Amino sugar derivatives
JPS62160696A (ja) * 1986-01-07 1987-07-16 シャープ株式会社 電子式自動点滅器
EP0257418B1 (de) * 1986-08-13 1993-05-19 Hoechst Aktiengesellschaft Oxiran-Pseudooligosaccharide, Verfahren zu deren Herstellung, deren Verwendung und pharmazeutische Präparate
US5464828A (en) * 1988-03-02 1995-11-07 Chugai Pharmaceutical Co., Ltd. Aqueous suspension of sucralfate
DE19507214A1 (de) * 1995-03-02 1996-10-31 Bayer Ag Acarbose-Biosynthesegene aus Actinoplanes sp., Verfahren zu ihrer Isolierung sowie ihre Verwendung
EP0796915A3 (de) * 1996-03-22 1999-04-14 Bayer Ag Verfahren zur Herstellung sowie zur Verwendung von Acarviosyl-Transferase bei der Umwandlung von Acarbose-Homologen in Acarbose, zur Herstellung von Acarbose-Homologen
DE19637591A1 (de) * 1996-09-13 1998-03-19 Bayer Ag Osmokontrolliertes Fermentationsverfahren zur Herstellung von Acarbose
US6649755B1 (en) 1999-10-28 2003-11-18 Chong Kun Dang Pharmaceutical Corp. Process for preparing acarbose with high purity
HRP20010792A2 (en) 2001-10-26 2003-04-30 Pliva D D Acarbose purification process
JP2015501641A (ja) 2011-12-08 2015-01-19 バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングBayer Intellectual Property GmbH 関連するアクチノバクテリアの遺伝的形質転換のためのプラスミドとしての、アクチノプラネス属se50/110由来の新規な放線菌組込み接合エレメント
US9352020B2 (en) 2013-03-15 2016-05-31 Mead Johnson Nutrition Company Reducing proinflammatory response
US9345727B2 (en) 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component and uses thereof
US9138455B2 (en) 2013-03-15 2015-09-22 Mead Johnson Nutrition Company Activating adiponectin by casein hydrolysate
US9345741B2 (en) 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional composition containing a peptide component with adiponectin simulating properties and uses thereof
US9289461B2 (en) 2013-03-15 2016-03-22 Mead Johnson Nutrition Company Reducing the risk of autoimmune disease
US8889633B2 (en) 2013-03-15 2014-11-18 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component with anti-inflammatory properties and uses thereof
KR20220081991A (ko) 2019-10-16 2022-06-16 바이엘 악티엔게젤샤프트 아카르보스의 개선된 형성을 위한 방법
US11802838B2 (en) 2020-03-23 2023-10-31 Bay State Milling Company Rapid high amylose wheat seed purity test

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3127315A (en) * 1964-03-31 Hypocholesterolemic agent m-

Also Published As

Publication number Publication date
NO135873B (pl) 1977-03-07
JPS6216638B2 (pl) 1987-04-14
JPS5734996B1 (pl) 1982-07-26
RO63065A (fr) 1979-02-15
JPS6234396B2 (pl) 1987-07-27
AU3721471A (en) 1973-09-27
FR2120073A1 (pl) 1972-08-11
ATA1111571A (de) 1975-09-15
DK139533B (da) 1979-03-05
NO135873C (pl) 1977-06-15
NL175199C (nl) 1984-10-01
SU454750A3 (ru) 1974-12-25
BG26002A4 (bg) 1979-01-12
RO61400A (pl) 1977-01-15
SE398357B (sv) 1977-12-19
AU461521B2 (en) 1975-05-29
DD99395A5 (pl) 1973-08-05
IL38441A (en) 1974-10-22
FI49774B (pl) 1975-06-30
BG26003A4 (bg) 1979-01-12
FI49774C (fi) 1975-10-10
IE35920L (en) 1972-06-28
BG25654A3 (bg) 1978-11-10
IE35920B1 (en) 1976-06-23
DE2064092A1 (de) 1972-07-20
PL82900B1 (pl) 1975-10-31
BE777387A (fr) 1972-06-28
JPS57150396A (en) 1982-09-17
AT330122B (de) 1976-06-10
CA979833A (en) 1975-12-16
ES398358A1 (es) 1974-09-01
NL175199B (nl) 1984-05-01
AR193370A1 (es) 1973-04-23
FR2120073B1 (pl) 1975-12-26
ZA718677B (en) 1972-09-27
CS167961B2 (pl) 1976-05-28
JPS57150395A (en) 1982-09-17
LU64319A1 (pl) 1972-06-13
NL7117893A (pl) 1972-06-30
IL38441A0 (en) 1972-02-29
DE2064092C2 (de) 1983-06-01
GB1374751A (en) 1974-11-20
US3876766A (en) 1975-04-08
CH594051A5 (pl) 1977-12-30
RO63064A (fr) 1978-06-15
KR780000248B1 (en) 1978-07-06

Similar Documents

Publication Publication Date Title
DK139533C (da) Fremgangsmaade til fremstilling af inhibitorer for fordoejelsesvejens alfa-glucosidaser
DK513578A (da) Fremgangsmaade til fremstilling af triazolylbenzopenoner
DK152050C (da) Analogifremgangsmaade til fremstilling af oxazolopyridiner
DK135699C (da) Fremgangsmaade til fremstilling af lynlaase
SE385118B (sv) Forfarande for framstellning av 2-(6-metoxi-2-naftyl)-propionsyra
DK150981C (da) Fremgangsmaade til fremstilling af diesterdiamider
DK560675A (da) Fremgangsmade til fremstilling af thiopyrimidinderivater
DK147499C (da) Fremgangsmaade til fremstilling af slidstaerke skinner
DK150143C (da) Analogifremgangsmaade til fremstilling af indolderivater
DK132273C (da) Fremgangsmade til fremstilling af trans-chrysanthemsyre
DK139524B (da) Fremgangsmaade til fremstilling af poly-alfahydroxy-acrylsyre
DK132586C (da) Fremgangsmade til fremstilling af erythromycylaminer
DK143847C (da) Analogifremgangsmaade til fremstilling af imidazolderivater
DK145540C (da) Fremgangsmaade til fremstilling af eventuelt i oploest form foreliggende cholinsalicylatsulfitholdige forbindelser
DK136034C (da) Analogifremgangsmade til fremstilling af sulfamoylpyrimidiner
DK133297C (da) Analogifremgangsmade til fremstilling af 6-halogen-6-cyklohexylindan-1-karbohydroxamsyre
DK141530C (da) Analogifremgangsmaade til fremstilling af lactamer
DK131786C (da) Fremgangsmade til fremstilling af delta4-3-oxo-1alfa-methylsteroider
DK140551B (da) Fremgangsmaade til fremstilling af diazabicycloalkanderivater
DK145932C (da) Fremgangsmaade til fremstilling af substituerede cobamider
DK139577C (da) Fremgangsmaade til fremstilling af des-phenylalaninb1-insulin
DK133277C (da) Fremgangsmade til fremstilling af trans-chrysanthemsyre
DK131376C (da) Analogifremgangsmade til fremstilling af monoestere af alfa-carboxybenzylpenicillin
DK132223C (da) Analogifremgangsmade til fremstilling af benzensulfonamidopyrimidiner
DK138447C (da) Fremgangsmaade til fremstilling af hexahydro-indan-4-carboxylsyreestere

Legal Events

Date Code Title Description
PBP Patent lapsed